1 / 9

Clinicopathological Conference

Clinicopathological Conference. CPC #1 September 8, 2009. Patient. 62 year old male DM II COPD Chronic Hepatitis B with mild fibrosis U/S 4 months ago no mass HTN Active Smoker. HPI. 4 weeks fatigue 10/10 RUQ pain – radiated to the back Jaundice Light/clay colored stools Nausea

lelia
Download Presentation

Clinicopathological Conference

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinicopathological Conference CPC #1 September 8, 2009

  2. Patient • 62 year old male • DM II • COPD • Chronic Hepatitis B with mild fibrosis • U/S 4 months ago no mass • HTN • Active Smoker

  3. HPI • 4 weeks fatigue • 10/10 RUQ pain – radiated to the back • Jaundice • Light/clay colored stools • Nausea • Dark urine

  4. At Risk • Hepatoma (3-4% risk per year) – Hepatitis B • Severe Infection – DM, COPD and Cirrhosis • FHF with appropriate trigger • Cancer risk – prostate, colorectal, lung

  5. Extrahepatic • Malignant • Cholangiocarcinoma • Pancreatic cancer • Gallbladder cancer • Ampullary cancer • Malignant involvement of the portahepatis lymph nodes • Hepatoma • Benign • Choledocholithiasis • Primary sclerosingcholangitis • Chronic pancreatitis • AIDS cholangiopathy • Stricture (benign)

  6. Differential Diagnosis • Hepatocellular Carcinoma • Correct Host • Fibrolamellar variant (nl AFP) • Pulmonary lesions • Cholangiocarcinoma • Ductal dilatation • Elevated CA 19-9

  7. Key points • Non-enhancing lesion on CT scan • Normal ultrasound 4 months ago • Normal AFP

  8. Cholangiocarcinoma • Adnocarcinoma of the epithelial cells of the biliary tract • 2-3,000 cases per year • Associated with primary sclerosing choangitis and chronic inflammation • Risk factors – parasitic liver infection (liver flukes) • Congenital liver abnormalities

  9. Diagnosis • Metastatic cholangiocarcinoma triggering fulminant hepatic failure in a patient with ETOH/Hep B cirrhosis

More Related